As we meet new clients one of the questions that’s frequently asked is “Why are you better than the design arm of a contract manufacturer, or an ODM (Original Design Manufacturer)?” Other than a few unique situations, our experience shows that it is always better to go with a design firm that does not have an exclusive manufacturing relationship ove
Stratos Group today announced the addition of Chris Rivera to its Board as a Life Science Adviser. Chris brings extensive experience in the life sciences to Stratos, including seven years as the President, and CEO of the Washington Biotechnology & Biomedical Association, where he fostered remarkable growth of the sector in Washington State. Prior to the WBBA, he spent more than 25 years at biotechnology companies, including Hyperion Therapeutics, where he was Founder and CEO, and Genzyme and Tercica, where he was Senior Vice President.
Joe Smith, MD, chief medical and science officer of the West Health Institute is on a mission. This mission is one he explained to attendees during his keynote at the recent OCTANe Medical Device Investment Forum in Irvine, CA, and it can be summed up in one word: Interoperation.
I recently had the honor to present my thoughts on Innovation and, moreover, how to make the word “Innovation” less scary in your everyday life. WE15, the annual conference of the Society of Women Engineers, welcomed over 8,000 individuals to Nashville, TN. About 50 of them joined me for a discussion of “Innovation’s Secret Weapon: The System Approach.”
It's an exciting time in the medical device industry, with new “cloud-connected” systems emerging every day that offer significant new value to patients and medical service providers. These new device systems—and even some implanted systems—do more than collect and display sensor and patient data; increasingly, they reach out wirelessly to the cloud for data storage, computation, and directed alerts. Read more about the areas to consider when developing a medical device system using the cloud connectivity model at MD+DI.
The WBBA recently hosted an interesting (and at times terrifying) panel titled “Superheroes Fighting Superbugs: Washington State on the Forefront of Antibiotic Resistance.”
The panel included moderator Lisa Cohen, Executive Director of the Washington Global Health Alliance; John Lynch, MD, Associated Professor in Medicine, Allergy and Infectious Diseases at Harborview Medical Center; Bruce Montgomery, MD, Chief Executive Officer of Cardeas Pharma; Michael Gluck, MD, Chief of Medicine at Virginia Mason Medical Center; Scott Weissman, MD, Assistant Professor, Pediatric Infectious Diseases at Seattle Children’s; and Anita Zaidi, Director of Enteric and Diarrheal Diseases for the Bill & Melinda Gates Foundation. The panel was an impressive representation of the work being done in Washington to combat the alarming and growing problem of multiple drug resistance.
Stratos Product Development announced today that it has been recommended for certification to ISO 13485:2003, the internationally recognized quality standard for medical devices.
The recommendation is a result of an extensive assessment performed by BSI Group, and indicates that Stratos’ Quality Management System has been effectively implemented to the requirements of ISO 13485.
This month the Washington Biotechnology & Biomedical Association (WBBA) held its 26th annual Governor's Life Sciences Summit and Annual Meeting at Bellevue’s Meydenbauer Center. The event offered a diverse group of speakers, including Jay Inslee, Governor of Washington State; Dow Constantine, King County Executive; Scott Palmer, Ernst & Young’s VP of Life Science Strategy Services; and Aaron Martin, Providence Health & Services’ Senior VP of Strategy and Innovation.